|
|
|
| home > pmps > summer 2003 > responding to nasal and pulmonary drug delivery trends |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
The importance of the implementation of drug delivery technologies into new drug products has risen considerably in recent years. The drug delivery industry is experiencing a growth rate of around 15 per cent per year, which is about double the growth of the overall pharmaceutical industry.
Various reasons, ranging from innovative technology to pharmacoeconomic issues, are contributing to the success of the drug delivery industry. In particular the administration of drug products via the nasal and pulmonary route offers the opportunity to open a new market.
The actual patient's position on these mucosal administration routes is increasingly important. It has to be realised that new drug delivery technologies can be successful in the market only as long as they are accepted by the patients themselves.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EMBALLAGE 2012
19-22 November 2012, Paris Nord Villepinte, France
EMBALLAGE has clearly delineated sectors to make the decision-maker’s task easier when visiting and to highlight all the industry’s know-how: machinery and packaging for the food and cosmetics sectors, health solutions and luxury packaging and containers, etc. Hence, EMBALLAGE provides a bespoke solution for each industry
More info >> |
|
 |
News and Press Releases |
 |
Norwich Expands Capabilities for Phase I-III Clinical Trials
Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced a significant expansion to its clinical research capabilities in order to meet growing market demand. Primary to the expansion, NCS unveiled a new clinical facility with capabilities to conduct all aspects of Phase I – III clinical trials including pharmacokinetics in healthy volunteers, bio-availability and bio-equivalence studies, drug metabolism studies, dose proportionality studies and multiple dose studies.
More info >> |
|
|
